Cleo Diagnostics (ASX:COV) Total Payout Ratio: 0.79 (As of Aug. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:COV Cleo Diagnostics Ltd ASX:COV
31 GF Score
Price A$0.34
! 1 Warning Sign
View Full Analysis

What is Cleo Diagnostics Total Payout Ratio?

Cleo Diagnostics ASX:COV +7.09% 31 Total Payout Ratio is 0.79 as of Aug. 25, 2026. GuruFocus rates ASX:COV with a GF Score™ of 31/100. The stock has 1 warning sign investors should review.

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Cleo Diagnostics's current Total Payout Ratio is 0.79.

Cleo Diagnostics Total Payout Ratio Related Terms

Cleo Diagnostics Total Payout Ratio Historical Data

* Premium members only.

The historical data trend for Cleo Diagnostics's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cleo Diagnostics Total Payout Ratio Chart

Cleo Diagnostics Annual Data
Trend Jun23 Jun24 Jun25 Jun26
Total Payout Ratio
0.00 2.97 0.00 0.79

Cleo Diagnostics Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Payout Ratio Get a 7-Day Free Trial 0.00 0.00 0.00 2.34 0.02

ASX:COV vs ABT, SYK, MDT: Total Payout Ratio Comparison

For the Medical Devices subindustry, Cleo Diagnostics's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cleo Diagnostics Total Payout Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cleo Diagnostics's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Cleo Diagnostics's Total Payout Ratio falls into.


ASX:COV
31GF Score
Cleo Diagnostics Ltd ASX:COV
Total Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cleo Diagnostics Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Cleo Diagnostics's Total Payout Ratio for the fiscal year that ended in Jun. 2025 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + 0) / -3.999
=0.00

Cleo Diagnostics's Total Payout Ratio for the quarter that ended in Dec. 2025 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-0.373 + 5.009 + 0) / -1.983
=2.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Payout Ratio →
What does a Total Payout Ratio of 0.79 mean?
Cleo Diagnostics (ASX:COV) has a Total Payout Ratio of 0.79 as of Aug. 25, 2026. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on Cleo Diagnostics and its competitors.
Is Cleo Diagnostics' Total Payout Ratio too high?
Cleo Diagnostics' current Total Payout Ratio is 0.79. Overall, Cleo Diagnostics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Cleo Diagnostics' Total Payout Ratio compare to ABT and SYK?
Cleo Diagnostics' Total Payout Ratio of 0.79 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Payout Ratio for a Medical Devices & Instruments company?
A good Total Payout Ratio depends on the Medical Devices & Instruments industry context. However, Total Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Payout Ratio mean?
A high Total Payout Ratio can signal that a stock is expensive relative to its fundamentals. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on Cleo Diagnostics and its competitors. Cleo Diagnostics's current Total Payout Ratio is 0.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cleo Diagnostics stock overvalued right now?
Cleo Diagnostics (ASX:COV) has a current Total Payout Ratio of 0.79. The current Total Payout Ratio is 0.79. Cleo Diagnostics' overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Payout Ratio calculated?
Total Payout Ratio is calculated from a company's financial statements. For Cleo Diagnostics (ASX:COV), the current Total Payout Ratio is 0.79 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cleo Diagnostics Business Description

Address 480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000
Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The company's first product to market is intended to be the Triage Test which results to accurately differentiate patients with malignant ovarian cancer from those with benign gynecological conditions. The company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.
31GF Score

Get the complete analysis for ASX:COV

Total Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.34
Price